SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001768824-20-000003
Filing Date
2020-05-27
Accepted
2020-05-27 11:59:53
Documents
1

Document Format Files

Seq Description Document Type Size
1 efc19-628_sc13d1227.htm SC 13D/A 183991
  Complete submission text file 0001768824-20-000003.txt   185390
Mailing Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036
Business Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036 212-776-4381
Ovid Therapeutics Inc. (Subject) CIK: 0001636651 (see all company filings)

IRS No.: 465270895 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90350 | Film No.: 20914046
SIC: 2834 Pharmaceutical Preparations

Mailing Address 100 NORTH BISCAYNE BLVD MIAMI FL 33132
Business Address 100 NORTH BISCAYNE BLVD MIAMI FL 33132 3122642196
TLS Advisors LLC (Filed by) CIK: 0001768824 (see all company filings)

IRS No.: 205570195
Type: SC 13D/A